SPIN1 accelerates tumorigenesis and confers radioresistance in non-small cell lung cancer by orchestrating the FOXO3a/FOXM1 axis
Open Access
- 15 November 2024
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (11) , 1-15
Abstract
Despite the importance of radiation therapy as a nonsurgical treatment for non-small cell lung cancer (NSCLC), radiation resistance has always been a concern because of poor patient response and outcomes. Therefore, it is crucial to identify novel targets to increase the effectiveness of radiotherapy and investigate the mechanisms underlying radioresistance. Previously, we demonstrated that Spindlin 1 (SPIN1) was related to tumour initiation and progression. In this study, we found that SPIN1 expression was higher in NSCLC tissues and cell lines than in the corresponding controls. SPIN1 overexpression in NSCLC patients was closely correlated with disease progression and poor prognosis. Functionally, SPIN1 depletion inhibited cell proliferation, decreased the percentage of cells in the G2/M phase and suppressed cell migration and invasion. Moreover, SPIN1 knockdown decreased the clonogenic capacity, impaired double-strand break (DSB) repair and increased NSCLC radiosensitivity. Mechanistically, forkhead box M1 (FOXM1) was identified as a key downstream effector of SPIN1 in NSCLC cells. Furthermore, SPIN1 was found to facilitate MDM2-mediated FOXO3a ubiquitination and degradation, leading to FOXM1 upregulation. Moreover, restoration of FOXM1 expression markedly abolished the inhibitory effects and increased radiosensitivity induced by SPIN1 depletion. These results indicate that the SPIN1-MDM2-FOXO3a/FOXM1 signalling axis is essential for NSCLC progression and radioresistance and could serve as a therapeutic target for increasing radiotherapy efficacy.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- Hsa_circ_0000129 drives tumor growth via sequestering miR‐485‐3p and upregulating SPIN1 in breast cancerJournal of Biochemical and Molecular Toxicology, 2022
- DRP1 contributes to head and neck cancer progression and induces glycolysis through modulated FOXM1/MMP12 axisMolecular Oncology, 2022
- E2F1‐activated SPIN1 promotes tumor growth via a MDM2‐p21‐E2F1 feedback loop in gastric cancerMolecular Oncology, 2020
- SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancerCancer Letters, 2020
- LINC00473/miR‐374a‐5p regulates esophageal squamous cell carcinoma via targeting SPIN1 to weaken the effect of radiotherapyJournal of Cellular Biochemistry, 2019
- miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathwayBiomedicine & Pharmacotherapy, 2017
- Suppression of SPIN1‐mediated PI3K–Akt pathway by miR‐489 increases chemosensitivity in breast cancerThe Journal of Pathology, 2016
- Cardiomyocyte cytokinesis score: a potential method for cardiomyocyte proliferationCell Biology International, 2014
- Targeting FOXM1 in cancerBiochemical Pharmacology, 2013
- FOXM1: From cancer initiation to progression and treatmentBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2012